環亞國際實業(01143.HK)擬"2供1"進行供股 最多籌6220萬港元
格隆匯10月15日丨環亞國際實業(01143.HK)公佈,公司建議按於記錄日期每持有2股現有股份獲發1股供股股份的基準以認購價每股供股股份0.20港元進行供股,透過向合資格股東發行最多325,773,210股供股股份(假設於記錄日期或之前全部未行使購股權均獲行使及公司股本並無其他變動)籌集最多約6520萬港元(扣除開支前)。
經扣除將由公司承擔的開支後,供股所得款項淨額估計不超過約6220萬港元(假設於記錄日期或之前全部未行使購股權均獲行使及公司股本並無其他變動)。假設供股所得款項淨額約為6220萬港元,公司擬將供股所得款項淨額其中(i)約3620萬港元用於擴展旗下電子製造服務及分銷產品業務的產品系列;(ii)約1810萬港元用於提供資金抓緊併購中國多個地區持牌輔助生殖服務提供者(即醫院及人工受孕中心等輔助生殖醫療設施)的潛在機遇、在該等地區開設新輔助生殖醫療中心及╱或營運該等醫療中心;及(iii)約790萬港元用於一般企業及營運資金。倘供股認購不足,供股所得款項淨額將根據上述用途按比例動用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.